Literature DB >> 12658817

Quantitative assessment of coronary flow reserve by the variables of time-intensity curve with myocardial contrast echocardiography.

Xiaping Yuan1, Xinfang Wang, Wangpeng Liu, Chunsong Kang.   

Abstract

The reliability and reliable indexes of quantitative assessment of coronary flow reserve (CFR) by using time-intensity curve (TIC) via myocardial contrast echocardiography were investigated. The TIC variables were obtained by employing acoustic densitometry (AD) technique before and after acetylcholine (Ach) injection in 12 dogs. Meanwhile, the correlation between these variables and CFR was analyzed. Among the variables derived from TIC, peak intensity (PI), area under the curve (AUC) and descending slope (DS) were increased significantly (P < 0.05) with the increase of coronary blood flow after Ach injection. Conversely, time-to-peak (TP), half-time of descent (HT), and mean-transit-time (MTT) were decreased remarkably (P < 0.0001). The PI and AUC ratios from post- to pre-Ach injection were strongly associated with CFR with the correlation coefficient (r) being 0.8366 and 0.8824, respectively. It is reliable by using the variables derived from TIC with myocardial contrast echocardiography to quantitatively evaluate regional myocardial CFR. The PI and AUC ratios from post- to pre-Ach injection are the reliable indexes for quantitative assessment of CFR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12658817     DOI: 10.1007/BF02828193

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  13 in total

Review 1.  Clinical applications of myocardial contrast echocardiography.

Authors:  S Kaul
Journal:  Am J Cardiol       Date:  1992-06-18       Impact factor: 2.778

Review 2.  Assessment of myocardial perfusion with contrast two-dimensional echocardiography.

Authors:  S Kaul
Journal:  Am J Med Sci       Date:  1990-02       Impact factor: 2.378

Review 3.  Current concepts of coronary flow reserve for clinical decision making during cardiac catheterization.

Authors:  D Baumgart; M Haude; F Liu; J Ge; G Goerge; R Erbel
Journal:  Am Heart J       Date:  1998-07       Impact factor: 4.749

4.  The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography.

Authors:  M W Keller; S S Segal; S Kaul; B Duling
Journal:  Circ Res       Date:  1989-08       Impact factor: 17.367

5.  Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary reserve by peak contrast intensity.

Authors:  J Cheirif; W A Zoghbi; A E Raizner; S T Minor; W L Winters; M S Klein; T L De Bauche; J M Lewis; R Roberts; M A Quinones
Journal:  J Am Coll Cardiol       Date:  1988-04       Impact factor: 24.094

6.  Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care.

Authors:  F J Klocke
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

7.  Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscle.

Authors:  A L Strauss; K D Beller
Journal:  Ultrasound Med Biol       Date:  1997       Impact factor: 2.998

8.  Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserve.

Authors:  M W Keller; W Glasheen; M L Smucker; L R Burwell; D D Watson; S Kaul
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

9.  Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation.

Authors:  S Iliceto; V Marangelli; C Memmola; P Rizzon
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

10.  Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humans.

Authors:  T R Porter; A D'Sa; C Turner; L A Jones; A J Minisi; P K Mohanty; G W Vetrovec; J V Nixon
Journal:  J Am Coll Cardiol       Date:  1993-02       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.